Print

About Us

about-usWho We Are

We are marketing, sales and analytical industry professionals with a deep background in strategy, predictive forecasting, and post event tracking and analysis for sales and marketing programs.

We are experienced at solving complex problems and providing key insights across more than 20+ core industries.   For the last 7 years, we have been focusing our solutions primarily on the pharmaceutical marketplace with a special emphasis on optimizing patent co-pay programs because of the huge spend almost all brands have in this area.  Our clients have found that our tools really help them understand the levers they can change to more closely align their program with their brand and corporate objectives.  We have continualy been recognized for providing uniquely innovative marketing solutions for the pharma industry.  Our suite of three co-pay program optimization models are recognized throughout the industry as the platinum standard for planning and evaluating these programs.

 

About Alpha 1C Founder, Al Kenney

Al Kenney SmAl Kenney has 30 years’ experience in sales, marketing, and analytics within the pharmaceutical, OTC, food, direct marketing, and software industries. Al’s expertise lies in the areas of marketing, sales, business process redesign, data, software application design, program implementation, forecasting, and the analysis and measurement of marketing and sales spending.

Al is the founder of Alpha 1C, a company focusing on producing low cost easy to use “what if” predictive modeling and measurement tools to  optimize a company’s sales and marketing spending. Prior to Alpha 1C, Al spent eight years in the software industry specifically focused on advanced analytics, supply chain, and forecasting. He founded, owned and operated Performance Wave Inc. a software company which also specialized in modeling and forecasting pricing and product assortment for both major Consumer Goods manufacturers and retailers. Performance Wave was sold in 1999. Later, he served as the General Manager for Demantra Inc., a leading provider of scenario optimization and program measurement software (which is now part of Oracle). Al spent 7 years at P&G where he served as Director of Category Management, and started his career at Whitehall labs (now Pfizer) where he had numerous sales, sales management, and internal sales support positions. Since 2006, Al has been applying his knowledge and skills specifically to the pharma and bio-technology industries.

 

About Alpha 1C

We are marketing, sales, and analytical industry professionals with a deep background in strategy, predictive forecasting, and post event tracking and analysis for sales and marketing programs (with a major focus on copay). We have vast experience solving complex problems and providing key insights across more than 20+ core industries. For the last 7 years, we have been focusing our solutions primarily on the Pharmaceutical and Bio-Tech marketplaces.

Alpha 1C provides award winning goals based predictive analytical models and analytic services to address both the financial and strategic issues facing pharma marketers, finance, and senior management. These provides key insights to brand teams allowing them to make more informed decisions that provide a better ROI. Our models actually recommend what the brand should be doing based on the brand’s current objectives and budget and are great for both existing brands and for product launches where getting the right offer is extremely important. Alpha 1C’s business model is to sell for a fixed price that is all-inclusive.   

We apply truly innovative thinking and a solid approach to your complex business problems and utilize our easy to use predictive analysis tools so you can quickly identify the information you need to run your business more productively and utilize the most profitable solutions to meet your business goals. Our work is easily paid for through the efficiencies and insights we bring to your business.  Alpha1C is headquartered in Sherman, Ct. and was founded in January 2012.